Weekly reads: diabetes, GvHD, Novo Nordisk & regenerative medicine, HDACs
Professor Paul Knoepfler, Ph.D.
Do many in the regenerative medicine field have favorite types of stem cells? Some seem to think there’s a tension between those working on pluripotent stem cells like iPS cells and those working with MSCs. I don’t see it that way, though. Whatever stem cells work best for a particular condition should be used and, […] The post Weekly reads: diabetes, GvHD, Novo Nordisk & regenerative medicine, HDACs appeared first on The Niche .